Safety and Efficacy of NK520 to Treat Relapsed/Refractory Acute Myeloid Leukemia

The number of NK520 cell infused for each dosing will be calculated based on body weight of subject. NK520 should be administered through intravenous infusion once a week, for a total of four times.